Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis

Zhai,Xiaofeng; Xue,Qingfeng; Liu,Qun; Guo,Yuyu; Chen,Zhe

doi:10.3892/mmr.2017.7412

Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis

Authors:
- Xiaofeng Zhai
- Qingfeng Xue
- Qun Liu
- Yuyu Guo
- Zhe Chen
View Affiliations

Affiliations: Department of Integrative Oncology, Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai 200433, P.R. China, Department of Anesthesiology, 264 Hospital of The People's Liberation Army, Taiyuan, Shanxi 030001, P.R. China
Published online on: August 31, 2017 https://doi.org/10.3892/mmr.2017.7412
Pages: 6499-6505
Copyright: © Zhai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to identify the recurrence‑associated genes in colon cancer, which may provide theoretical evidence for the development of novel methods to prevent tumor recurrence. Colon cancer and matched normal samples microarray data (E‑GEOD‑39582) were downloaded from ArrayExpress. Genes with significant variation were identified, followed by the screening of differentially expressed genes (DEGs). Subsequently, the co‑expression network of DEGs was constructed using the weighted correlation network analysis (WGCNA) method, which was verified using the validation dataset. The significant modules associated with recurrence in the network were subsequently screened and verified in another independent dataset E‑GEOD‑33113. Function and pathway enrichment analyses were also conducted to determine the roles of selected genes. Survival analysis was performed to identify the association between these genes and survival. A total of 434 DEGs were identified in the colon samples, and stress‑associated endoplasmic reticulum protein family member 2 (SERP2) and long non‑coding RNA‑0219 (LINC0219) were determined to be the vital DEGs between all the three sub‑type groups with different clinical features. The brown module was identified to be the most significant module in the co‑expression network associated with the recurrence of colon cancer, which was verified in the E‑GEOD‑33113 dataset. Top 10 genes in the brown module, including EGF containing fibulin like extracellular matrix protein 2 (EFEMP2), fibrillin 1 (FBN1) and secreted protein acidic and cysteine rich (SPARC) were also associated with survival time of colon cancer patients. Further analysis revealed that the function of cell adhesion, biological adhesion, extracellular matrix (ECM) organization, pathways of ECM‑receptor interaction and focal adhesion were the significantly changed terms in colon cancer. In conclusion, SERP2, EFEMP2, FBN1, SPARC, and LINC0219 were revealed to be the recurrence‑associated molecular and prognostic indicators in colon cancer by WGCNA co‑expression network analysis.

View Figures

View References

1	American Cancer Society, . Colorectal cancer facts & figures, 2011–2013. Atlanta, GA: American Cancer Society; 2011
2	Liang Z, Baige L, Shen G, Lina S, Lingxia L and Chengyan H: Study on the Serum Periostin Concentrations of colon cancer patients. Chin J Lab Dia. 4:422015.
3	Yangming G, Chunxiao W, Minlu Z, Minlu Z, Peng P, Kai GU, Pingping B, Zhezhou H, Yongmei X and Ying Z: Colorectal cancer survival analysis in major areas in Shanghai. China Oncol. 25:497–504. 2015.
4	Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, et al: Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res. 17:6934–6943. 2011. View Article : Google Scholar : PubMed/NCBI
5	Duffy M, Lamerz R, Haglund C, Nicolini A, Kalousová M, Holubec L and Sturgeon C: Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer. 134:2513–2522. 2014. View Article : Google Scholar : PubMed/NCBI
6	Juo YY, Johnston FM, Zhang DY, Juo HH, Wang H, Pappou EP, Yu T, Easwaran H, Baylin S, van Engeland M and Ahuja N: Prognostic value of CpG island methylator phenotype among colorectal cancer patients: A systematic review and meta-analysis. Ann Oncol. 25:2314–2327. 2014. View Article : Google Scholar : PubMed/NCBI
7	Sanders MA and Majumdar AP: Colon cancer stem cells: Implications in carcinogenesis. Front Biosci (Landmark Ed). 16:1651–1662. 2011. View Article : Google Scholar : PubMed/NCBI
8	Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Alea M Perez, Richel DJ, Stassi G and Medema JP: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 105:13427–13432. 2008; View Article : Google Scholar : PubMed/NCBI
9	Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC, Kim NK and Issa JP: DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 117:1847–1854. 2011. View Article : Google Scholar : PubMed/NCBI
10	Yang IP, Tsai HL, Hou MF, Chen KC, Tsai PC, Huang SW, Chou WW, Wang JY and Juo SH: MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis. 33:1522–1530. 2012. View Article : Google Scholar : PubMed/NCBI
11	Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, et al: Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 367:1596–1606. 2012. View Article : Google Scholar : PubMed/NCBI
12	Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
13	da W Huang, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
14	Richardson J, Viswanathan K and Lucas A: Serpins, the vasculature, and viral therapeutics. Front Biosci. 11:1042–1056. 2006. View Article : Google Scholar : PubMed/NCBI
15	Zhang X, Song YF, Lu HN, Wang DP, Zhang XS, Huang SL, Sun BL and Huang ZG: Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. World J Gastroenterol. 21:2629–2637. 2015. View Article : Google Scholar : PubMed/NCBI
16	Ning L, Haixing J, Zhenyu H, Shanyu Q and Xin L: Expression of SFRP2, β-catenin and their roles in colorectal carcinoma. J Dig Oncol (Electronic Version). 2008.
17	Shi Y, Liu Y, Wang J, Jie D, Yun T, Li W, Yan L, Wang K and Feng J: Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal cancer cells via downregualtion of p21 expression. PLoS One. 10:e01226792015. View Article : Google Scholar : PubMed/NCBI
18	Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
19	Ge X, Chen Y, Liao X, Liu D, Li F, Ruan H and Jia W: Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med Oncol. 30:5882013. View Article : Google Scholar : PubMed/NCBI
20	Yao L, Lao W, Zhang Y, Tang X, Hu X, He C, Hu X and Xu LX: Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues. J Proteome Res. 11:3281–3294. 2012. View Article : Google Scholar : PubMed/NCBI
21	McPherson RA and Pincus MR: Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd edition. Elsevier Saunders; Philadelphia, PA: 2011, View Article : Google Scholar
22	Guo Q, Song Y, Zhang H, Wu X, Xia P and Dang C: Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients. Med Oncol. 30:6952013. View Article : Google Scholar : PubMed/NCBI
23	Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C and Lawrance IC: SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer. PLoS One. 6:e220472011. View Article : Google Scholar : PubMed/NCBI
24	Liang JF, Wang HK, Xiao H, Li N, Cheng CX, Zhao YZ, Ma YB, Gao JZ, Bai RB and Zheng HX: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res. 29:712010. View Article : Google Scholar : PubMed/NCBI
25	Lascorz J, Chen B, Hemminki K and Försti A: Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS One. 6:e188672011. View Article : Google Scholar : PubMed/NCBI